Cerus Corporation (CERS)
USD 1.21
(-6.2%)
USD 1.21
(-6.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 86.4 Million USD | -3.55% |
| 2022 | 87.09 Million USD | 29.25% |
| 2021 | 67.38 Million USD | 32.74% |
| 2020 | 50.76 Million USD | 23.12% |
| 2019 | 41.23 Million USD | 40.84% |
| 2018 | 29.27 Million USD | 39.15% |
| 2017 | 21.03 Million USD | 24.57% |
| 2016 | 16.88 Million USD | 56.97% |
| 2015 | 10.75 Million USD | -29.8% |
| 2014 | 15.32 Million USD | -10.13% |
| 2013 | 17.05 Million USD | 6.07% |
| 2012 | 16.07 Million USD | 10.82% |
| 2011 | 14.5 Million USD | 31.15% |
| 2010 | 11.06 Million USD | 104.79% |
| 2009 | 5.4 Million USD | -21.01% |
| 2008 | 6.83 Million USD | 17.59% |
| 2007 | 5.81 Million USD | -82.91% |
| 2006 | 34.03 Million USD | 39.67% |
| 2005 | 24.37 Million USD | 75.19% |
| 2004 | 13.91 Million USD | 43.93% |
| 2003 | 9.66 Million USD | 13.84% |
| 2002 | 8.49 Million USD | 87.21% |
| 2001 | 4.53 Million USD | 82.49% |
| 2000 | 2.48 Million USD | -17.17% |
| 1999 | 3 Million USD | -16.67% |
| 1998 | 3.6 Million USD | -52.63% |
| 1997 | 7.6 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 21.27 Million USD | -15.96% |
| 2024 Q3 | 26.19 Million USD | 6.22% |
| 2024 Q2 | 24.66 Million USD | 15.96% |
| 2023 Q4 | 25.31 Million USD | 16.02% |
| 2023 Q1 | 17.28 Million USD | -29.54% |
| 2023 FY | 84 Million USD | -3.55% |
| 2023 Q2 | 21.33 Million USD | 23.43% |
| 2023 Q3 | 21.81 Million USD | 2.24% |
| 2022 Q4 | 24.53 Million USD | 11.99% |
| 2022 FY | 87.09 Million USD | 29.25% |
| 2022 Q2 | 21.28 Million USD | 9.88% |
| 2022 Q3 | 21.9 Million USD | 2.95% |
| 2022 Q1 | 19.36 Million USD | -5.01% |
| 2021 Q2 | 16.16 Million USD | 31.56% |
| 2021 FY | 67.38 Million USD | 32.74% |
| 2021 Q4 | 20.39 Million USD | 9.93% |
| 2021 Q3 | 18.54 Million USD | 14.78% |
| 2021 Q1 | 12.28 Million USD | -23.32% |
| 2020 Q4 | 16.02 Million USD | 26.6% |
| 2020 Q2 | 11.79 Million USD | 14.64% |
| 2020 Q3 | 12.65 Million USD | 7.26% |
| 2020 FY | 50.76 Million USD | 23.12% |
| 2020 Q1 | 10.29 Million USD | -11.47% |
| 2019 Q4 | 11.62 Million USD | 11.38% |
| 2019 Q1 | 9.07 Million USD | 12.24% |
| 2019 FY | 41.23 Million USD | 40.84% |
| 2019 Q2 | 10.09 Million USD | 11.31% |
| 2019 Q3 | 10.43 Million USD | 3.35% |
| 2018 Q3 | 7.25 Million USD | -5.75% |
| 2018 Q2 | 7.7 Million USD | 23.52% |
| 2018 Q4 | 8.08 Million USD | 11.38% |
| 2018 Q1 | 6.23 Million USD | -12.33% |
| 2018 FY | 29.27 Million USD | 39.15% |
| 2017 Q2 | 5.16 Million USD | 55.95% |
| 2017 Q1 | 3.31 Million USD | -26.73% |
| 2017 Q3 | 5.44 Million USD | 5.5% |
| 2017 Q4 | 7.11 Million USD | 30.5% |
| 2017 FY | 21.03 Million USD | 24.57% |
| 2016 Q1 | 3.36 Million USD | -3.58% |
| 2016 Q2 | 4.27 Million USD | 26.89% |
| 2016 Q3 | 4.72 Million USD | 10.5% |
| 2016 Q4 | 4.52 Million USD | -4.32% |
| 2016 FY | 16.88 Million USD | 56.97% |
| 2015 FY | 10.75 Million USD | -29.8% |
| 2015 Q4 | 3.49 Million USD | 40.6% |
| 2015 Q3 | 2.48 Million USD | 37.9% |
| 2015 Q2 | 1.8 Million USD | -39.49% |
| 2015 Q1 | 2.97 Million USD | -3.81% |
| 2014 Q3 | 4.67 Million USD | 21.41% |
| 2014 Q1 | 3.7 Million USD | -13.6% |
| 2014 FY | 15.32 Million USD | -10.13% |
| 2014 Q4 | 3.09 Million USD | -33.75% |
| 2014 Q2 | 3.84 Million USD | 3.77% |
| 2013 Q1 | 4.64 Million USD | -14.19% |
| 2013 Q4 | 4.29 Million USD | 15.53% |
| 2013 Q3 | 3.71 Million USD | -15.6% |
| 2013 Q2 | 4.4 Million USD | -5.17% |
| 2013 FY | 17.05 Million USD | 6.07% |
| 2012 FY | 16.07 Million USD | 10.82% |
| 2012 Q4 | 5.41 Million USD | 40.87% |
| 2012 Q3 | 3.84 Million USD | 5.23% |
| 2012 Q2 | 3.65 Million USD | 11.69% |
| 2012 Q1 | 3.26 Million USD | -17.5% |
| 2011 Q2 | 2.77 Million USD | -12.57% |
| 2011 Q3 | 4.59 Million USD | 65.73% |
| 2011 Q4 | 3.96 Million USD | -13.87% |
| 2011 FY | 14.5 Million USD | 31.15% |
| 2011 Q1 | 3.17 Million USD | 12.12% |
| 2010 FY | 11.06 Million USD | 104.79% |
| 2010 Q2 | 3 Million USD | 17.04% |
| 2010 Q1 | 2.56 Million USD | 46.51% |
| 2010 Q4 | 2.83 Million USD | 6.15% |
| 2010 Q3 | 2.66 Million USD | -11.13% |
| 2009 Q1 | 1.39 Million USD | 110.57% |
| 2009 Q3 | 572 Thousand USD | -66.07% |
| 2009 Q2 | 1.68 Million USD | 20.95% |
| 2009 Q4 | 1.75 Million USD | 205.94% |
| 2009 FY | 5.4 Million USD | -21.01% |
| 2008 Q3 | 1.96 Million USD | 106.61% |
| 2008 FY | 6.83 Million USD | 17.59% |
| 2008 Q4 | 662 Thousand USD | -66.38% |
| 2008 Q2 | 953 Thousand USD | -70.72% |
| 2008 Q1 | 3.25 Million USD | 192.16% |
| 2007 Q3 | 2.02 Million USD | -41.2% |
| 2007 Q1 | 3.87 Million USD | -71.18% |
| 2007 Q4 | -3.53 Million USD | -274.25% |
| 2007 FY | 5.81 Million USD | -82.91% |
| 2007 Q2 | 3.44 Million USD | -11.02% |
| 2006 FY | 34.03 Million USD | 39.67% |
| 2006 Q3 | 7.6 Million USD | 23.01% |
| 2006 Q4 | 13.44 Million USD | 76.87% |
| 2006 Q1 | 6.81 Million USD | 21.48% |
| 2006 Q2 | 6.17 Million USD | -9.33% |
| 2005 Q1 | 6.4 Million USD | 116.32% |
| 2005 Q2 | 5.48 Million USD | -14.39% |
| 2005 Q3 | 6.88 Million USD | 25.55% |
| 2005 FY | 24.37 Million USD | 75.19% |
| 2005 Q4 | 5.61 Million USD | -18.46% |
| 2004 Q1 | 3.64 Million USD | 3.46% |
| 2004 Q2 | 3.76 Million USD | 3.26% |
| 2004 Q3 | 3.53 Million USD | -6.03% |
| 2004 Q4 | 2.95 Million USD | -16.39% |
| 2004 FY | 13.91 Million USD | 43.93% |
| 2003 Q3 | 2.86 Million USD | 43.19% |
| 2003 Q2 | 2 Million USD | 57.84% |
| 2003 Q4 | 3.52 Million USD | 22.91% |
| 2003 Q1 | 1.26 Million USD | -21.08% |
| 2003 FY | 9.66 Million USD | 13.84% |
| 2002 Q3 | 730 Thousand USD | -87.08% |
| 2002 Q1 | 503 Thousand USD | -50.44% |
| 2002 FY | 8.49 Million USD | 87.21% |
| 2002 Q2 | 5.64 Million USD | 1023.06% |
| 2002 Q4 | 1.6 Million USD | 120.27% |
| 2001 Q2 | 1.55 Million USD | 7.96% |
| 2001 FY | 4.53 Million USD | 82.49% |
| 2001 Q4 | 1.01 Million USD | 96.32% |
| 2001 Q3 | 517 Thousand USD | -66.84% |
| 2001 Q1 | 1.44 Million USD | 245.45% |
| 2000 FY | 2.48 Million USD | -17.17% |
| 2000 Q1 | 775 Thousand USD | 158.33% |
| 2000 Q4 | 418 Thousand USD | -31.36% |
| 2000 Q3 | 609 Thousand USD | -10.83% |
| 2000 Q2 | 683 Thousand USD | -11.87% |
| 1999 Q3 | 1.2 Million USD | 140.0% |
| 1999 Q1 | 900 Thousand USD | 80.0% |
| 1999 FY | 3 Million USD | -16.67% |
| 1999 Q4 | 300 Thousand USD | -75.0% |
| 1999 Q2 | 500 Thousand USD | -44.44% |
| 1998 Q2 | 800 Thousand USD | -55.56% |
| 1998 Q1 | 1.8 Million USD | 12.5% |
| 1998 FY | 3.6 Million USD | -52.63% |
| 1998 Q3 | 500 Thousand USD | -37.5% |
| 1998 Q4 | 500 Thousand USD | 0.0% |
| 1997 Q3 | 3.5 Million USD | 169.23% |
| 1997 Q2 | 1.3 Million USD | 8.33% |
| 1997 FY | 7.6 Million USD | 0.0% |
| 1997 Q1 | 1.2 Million USD | 0.0% |
| 1997 Q4 | 1.6 Million USD | -54.29% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -3288.235% |
| BrainsWay Ltd. | 23.09 Million USD | -274.172% |
| Envoy Medical, Inc. | -473 Thousand USD | 18366.385% |
| electroCore, Inc. | 13.22 Million USD | -553.259% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -141539.344% |
| IceCure Medical Ltd | 1.3 Million USD | -6546.154% |
| Inogen, Inc. | 126.69 Million USD | 31.807% |
| OrthoPediatrics Corp. | 111.25 Million USD | 22.339% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 1528.099% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 182624.928% |
| MaxCyte, Inc. | 36.54 Million USD | -136.414% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -18825.911% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -101475.359% |
| Orthofix Medical Inc. | 486.27 Million USD | 82.232% |
| PAVmed Inc | -3.96 Million USD | 2277.419% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 1675.205% |
| RxSight, Inc. | 53.76 Million USD | -60.699% |
| Sight Sciences, Inc. | 69.17 Million USD | -24.901% |
| SI-BONE, Inc. | 109.42 Million USD | 21.038% |
| TELA Bio, Inc. | 40.11 Million USD | -115.397% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 43.134% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -944.614% |
| Acutus Medical, Inc. | -3.13 Million USD | 2854.224% |
| Talis Biomedical Corporation | 371 Thousand USD | -23188.41% |
| Spectral AI, Inc. | 7.88 Million USD | -996.447% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 1410.68% |
| CVRx, Inc. | 33.03 Million USD | -161.509% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -11583.159% |
| Bioventus Inc. | 328.19 Million USD | 73.674% |
| Venus Concept Inc. | 52.16 Million USD | -65.622% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -443.191% |
| LivaNova PLC | 771.25 Million USD | 88.797% |
| 908 Devices Inc. | 25.32 Million USD | -241.205% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 72.147% |
| Nemaura Medical Inc. | -1.47 Million USD | 5952.104% |
| NeuroPace, Inc. | 48.12 Million USD | -79.544% |
| LENSAR, Inc. | 21.1 Million USD | -309.343% |
| Apyx Medical Corporation | 14.12 Million USD | -511.811% |
| Cutera, Inc. | 41.49 Million USD | -108.223% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -368.014% |
| BioSig Technologies, Inc. | 18 Thousand USD | -479900.0% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 16.188% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -534.641% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 90.275% |
| Axonics, Inc. | 274.55 Million USD | 68.531% |
| Outset Medical, Inc. | 29 Million USD | -197.931% |
| IRIDEX Corporation | 21.8 Million USD | -296.203% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | -21.606% |
| IRadimed Corporation | 50.15 Million USD | -72.255% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -30004.53% |
| INVO Bioscience, Inc. | 1.08 Million USD | -7854.79% |
| Telesis Bio, Inc. | 16.95 Million USD | -409.735% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 23.393% |
| Varex Imaging Corporation | 256.9 Million USD | 66.368% |
| Quipt Home Medical Corp. | 163.84 Million USD | 47.267% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 21380.788% |
| Pulmonx Corporation | 50.75 Million USD | -70.24% |
| Dynatronics Corporation | 7.63 Million USD | -1031.634% |
| Modular Medical, Inc. | -768 Thousand USD | 11350.0% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -1457.318% |
| Semler Scientific, Inc. | 61.2 Million USD | -41.176% |
| InMode Ltd. | 411.34 Million USD | 78.995% |
| Bruker Corporation | 1.51 Billion USD | 94.304% |
| Cytosorbents Corporation | 22.39 Million USD | -285.852% |
| DexCom, Inc. | 2.28 Billion USD | 96.225% |
| Align Technology, Inc. | 2.71 Billion USD | 96.822% |
| Viveve Medical, Inc. | 620 Thousand USD | -13835.484% |
| ZimVie Inc. | 290.38 Million USD | 70.246% |
| Movano Inc. | -158 Thousand USD | 54783.544% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 21.043% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -101475.359% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 76.502% |
| Profound Medical Corp. | 4.51 Million USD | -1814.036% |
| Insulet Corporation | 1.15 Billion USD | 92.551% |
| enVVeno Medical Corporation | -546 Thousand USD | 15924.176% |
| Surmodics, Inc. | 93.05 Million USD | 7.149% |
| iCAD, Inc. | 14.53 Million USD | -494.386% |
| Nuwellis, Inc. | 4.98 Million USD | -1633.895% |
| Biotricity, Inc. | 8.35 Million USD | -933.953% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 73.961% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 24163.032% |
| InspireMD, Inc. | 1.8 Million USD | -4681.406% |
| PAVmed Inc. | -3.96 Million USD | 2277.419% |
| BIOLASE, Inc. | 16.72 Million USD | -416.623% |
| Beyond Air, Inc. | -1.3 Million USD | 6710.559% |
| FONAR Corporation | 45.14 Million USD | -91.404% |
| AxoGen, Inc. | 127.87 Million USD | 32.433% |
| Vivani Medical, Inc. | -357 Thousand USD | 24301.681% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 55.723% |
| Inari Medical, Inc. | 434.56 Million USD | 80.118% |
| UFP Technologies, Inc. | 112.22 Million USD | 23.012% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -690050.971% |
| Tenon Medical, Inc. | 1.24 Million USD | -6862.127% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 106766.667% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -3188.811% |
| AdaptHealth Corp. | 479.56 Million USD | 81.984% |
| Sintx Technologies, Inc. | 1.84 Million USD | -4588.009% |
| NanoVibronix, Inc. | 1.53 Million USD | -5521.34% |
| Quanterix Corporation | 70.64 Million USD | -22.3% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 21380.788% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -514.509% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | -63.698% |
| TransMedics Group, Inc. | 154.09 Million USD | 43.93% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -1840.265% |
| NeuroMetrix, Inc. | 3.94 Million USD | -2088.775% |
| Hyperfine, Inc. | 4.75 Million USD | -1716.271% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 19.235% |
| Biomerica, Inc. | 611 Thousand USD | -14040.753% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -107.257% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 11163.378% |
| Silk Road Medical, Inc | 127.08 Million USD | 32.015% |